Cargando…
Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations
Despite effective pharmacological treatments for psychotic symptoms (eg, hallucinations, delusions), functional outcomes for people with psychotic disorders are often disappointing. Although it is not included in the diagnostic criteria for psychotic disorders, cognitive impairment is one of the str...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829172/ https://www.ncbi.nlm.nih.gov/pubmed/31749648 http://dx.doi.org/10.31887/DCNS.2019.21.3/amccleery |
_version_ | 1783465491624361984 |
---|---|
author | McCleery, Amanda Nuechterlein, Keith H. |
author_facet | McCleery, Amanda Nuechterlein, Keith H. |
author_sort | McCleery, Amanda |
collection | PubMed |
description | Despite effective pharmacological treatments for psychotic symptoms (eg, hallucinations, delusions), functional outcomes for people with psychotic disorders are often disappointing. Although it is not included in the diagnostic criteria for psychotic disorders, cognitive impairment is one of the strongest determinants of community functioning in this clinical population, and thus it is an important target for intervention. In this review, we discuss the major areas of research regarding impaired cognition in psychotic illness. The specific topics covered include: (i) the prevalence of cognitive impairment in psychotic disorders; (ii) the profile and magnitude of cognitive impairment in psychotic disorders; (iii) the developmental course of cognitive impairment; (iv) the longitudinal stability of cognitive impairment; and (v) treatment approaches to improve cognitive performance in people with psychotic disorders.
|
format | Online Article Text |
id | pubmed-6829172 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Les Laboratoires Servier |
record_format | MEDLINE/PubMed |
spelling | pubmed-68291722019-11-20 Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations
McCleery, Amanda Nuechterlein, Keith H. Dialogues Clin Neurosci Original Article Despite effective pharmacological treatments for psychotic symptoms (eg, hallucinations, delusions), functional outcomes for people with psychotic disorders are often disappointing. Although it is not included in the diagnostic criteria for psychotic disorders, cognitive impairment is one of the strongest determinants of community functioning in this clinical population, and thus it is an important target for intervention. In this review, we discuss the major areas of research regarding impaired cognition in psychotic illness. The specific topics covered include: (i) the prevalence of cognitive impairment in psychotic disorders; (ii) the profile and magnitude of cognitive impairment in psychotic disorders; (iii) the developmental course of cognitive impairment; (iv) the longitudinal stability of cognitive impairment; and (v) treatment approaches to improve cognitive performance in people with psychotic disorders.
Les Laboratoires Servier 2019-09 /pmc/articles/PMC6829172/ /pubmed/31749648 http://dx.doi.org/10.31887/DCNS.2019.21.3/amccleery Text en © 2019, AICH – Servier GroupCopyright © 2019 AICH – Servier Group. All rights reserved http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article McCleery, Amanda Nuechterlein, Keith H. Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations |
title | Cognitive impairment in psychotic illness: prevalence, profile of impairment,
developmental course, and treatment considerations
|
title_full | Cognitive impairment in psychotic illness: prevalence, profile of impairment,
developmental course, and treatment considerations
|
title_fullStr | Cognitive impairment in psychotic illness: prevalence, profile of impairment,
developmental course, and treatment considerations
|
title_full_unstemmed | Cognitive impairment in psychotic illness: prevalence, profile of impairment,
developmental course, and treatment considerations
|
title_short | Cognitive impairment in psychotic illness: prevalence, profile of impairment,
developmental course, and treatment considerations
|
title_sort | cognitive impairment in psychotic illness: prevalence, profile of impairment,
developmental course, and treatment considerations
|
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829172/ https://www.ncbi.nlm.nih.gov/pubmed/31749648 http://dx.doi.org/10.31887/DCNS.2019.21.3/amccleery |
work_keys_str_mv | AT mccleeryamanda cognitiveimpairmentinpsychoticillnessprevalenceprofileofimpairmentdevelopmentalcourseandtreatmentconsiderations AT nuechterleinkeithh cognitiveimpairmentinpsychoticillnessprevalenceprofileofimpairmentdevelopmentalcourseandtreatmentconsiderations |